 Home > Biochemistry News > Biotechnology News > Nearly 60% of patients' skin symptoms are almost completely cleared!

Nearly 60% of patients' skin symptoms are almost completely cleared!

 Last Update: 2022-08-15
 Source: Internet
 Author: User

Tags

new jersey laboratories

ability moderate temperature

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Bristol-Myers Squibb (BMS) today announced two-year results from the POETYK PSO Long-Term Extension (LTE) trial, supporting the durable efficacy and consistent safety profile of deucravicitinib in adults with moderate-to-severe plaque psorias.

Psoriasis is a widespread chronic systemic immune-mediated disease and a serious global problem, affecting at least 100 million people worldwi.

Deucravicitinib is an oral, selective tyrosine kinase 2 (TYK2) allosteric inhibitor with a unique mechanism of acti.

▲ Deucravicitinib has a unique mechanism of action (Image source: Bristol-Myers Squibb official website)

The overall safety results observed for deucravicitinib are consistent with previously published results from the pivotal Phase 3 POETYK PSO-1 and POETYK PSO-2 clinical tria.

"At BMS, our cutting-edge research leads to novel, well-tolerated potential treatment options for patients affected by severe immune-mediated diseases such as psoriasis," said Jonathan Sadeh, PhD, Senior Vice President, Immunology and Fibrosis Development at B.

References

[1] New Two-Year Deucravacitinib Data Reinforce Durable Efficacy and Consistent Safety Profile in Treatment of Moderate to Severe Plaque Psorias.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.